Adoptive cell transfer (ACT) therapies are growing in popularity due to their ability to interact
with diseased tissues in a specific manner. Disc-shaped particles, or “backpacks”, that bind …

Natural organisms have evolved sophisticated and multiscale hierarchical structures over
time to enable survival. Currently, bionic design is revolutionizing drug delivery systems …

Tumour-associated neutrophils can exert antitumour effects but can also assume a pro-
tumoural phenotype in the immunosuppressive tumour microenvironment. Here we show …

Traumatic brain injury (TBI) is a debilitating disease with no current therapies outside of
acute clinical management. While acute, controlled inflammation is important for debris …

Cellular hitchhiking is an emerging strategy for the in vivo control of adoptively transferred
immune cells. Hitchhiking approaches are primarily mediated by adhesion of nano and …

B cells, despite their several unique functionalities, remain largely untapped for use as an
adoptive cell therapy and are limited to in vitro use for antibody production. B cells can be …

Adoptive cell therapies are dramatically altering the treatment landscape of cancer.
However, treatment of solid tumors remains a major unmet need, in part due to limited …

Many emerging cancer treatments are immunotherapies that modulate Natural Killer‐(NK) or
T cell activation, posing a challenge to develop immunoengineering nanomaterials that …

Designing and assembling artificial cells (ACs) is a core direction in bottom‐up synthetic
biology. Here, the advancements in the past 3 years in engineering ACs with focus on …

Natural killer (NK) cells, which are an exciting alternative cell source for cancer
immunotherapies, must sense and respond to their physical environment to traffic to and …